Literature DB >> 33122098

HPV post-infection microenvironment and cervical cancer.

Yi Yuan1, Xushan Cai2, Fangrong Shen3, Feng Ma4.   

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted virus worldwide. More than 99% of cervical cancer cases are associated with certain types of HPVs, termed high-risk types. In addition to the well-known transformative properties, HPVs-infected cells actively instruct the local milieu and create a supportive post-infection microenvironment (PIM), which is becoming recognized as a key factor for the viral persistence, propagation, and malignant progression. The PIM is initiated and established via a complex interplay among virus-infected cells, immune cells, and host stroma, as well as their derived components including chemokines, cytokines, extracellular vesicles, and metabolites. In this review, we summarize the current understanding of these key components, characteristics, and effects of the PIM, and highlights the prospect of targeting the PIM as a potential strategy to improve therapeutic outcomes for cervical cancer.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HPV infection; Immune regulation; PIM; Papillomaviruses; Sexually transmitted virus

Year:  2020        PMID: 33122098     DOI: 10.1016/j.canlet.2020.10.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  24 in total

1.  P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells.

Authors:  Yue Han; Can Bai; Xi-Meng He; Qing-Ling Ren
Journal:  Purinergic Signal       Date:  2022-03-02       Impact factor: 3.765

Review 2.  Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets.

Authors:  Maria Luiza Mukai Franciosi; Thiago Inácio Teixeira do Carmo; Daniela Zanini; Andréia Machado Cardoso
Journal:  Inflamm Res       Date:  2022-04-04       Impact factor: 4.575

3.  The prognostic value of chemotherapy or/and radiotherapy in adenoid cystic carcinoma and adenoid basal carcinoma of the uterine cervix.

Authors:  Kun Liu; Yong Shi; Lili Qiao; Guodong Deng; Ning Liang; Jian Xie
Journal:  Ann Transl Med       Date:  2022-05

Review 4.  Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.

Authors:  Riccardo Di Fiore; Sherif Suleiman; Rosa Drago-Ferrante; Yashwanth Subbannayya; Francesca Pentimalli; Antonio Giordano; Jean Calleja-Agius
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

5.  GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer.

Authors:  Yan-Long Shi; Ming-Bo Liu; Hong-Ting Wu; Ye Han; Xuan He
Journal:  Dis Markers       Date:  2022-07-07       Impact factor: 3.464

6.  Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment.

Authors:  Fangfang Xu; Jiacheng Shen; Shaohua Xu
Journal:  Front Cell Dev Biol       Date:  2021-01-21

7.  HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression.

Authors:  Chenchen Hu; Tianyue Liu; Chenying Han; Yuxin Xuan; Dongbo Jiang; Yuanjie Sun; Xiyang Zhang; Wenxin Zhang; Yiming Xu; Yang Liu; Jingyu Pan; Jing Wang; Jiangjiang Fan; Yinggang Che; Yinan Huang; Jiaxing Zhang; Jiaqi Ding; Shuya Yang; Kun Yang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

8.  A New HPV score System Predicts the Survival of Patients With Cervical Cancers.

Authors:  Qunchao Hu; Yani Wang; Yuchen Zhang; Yanjun Ge; Yihua Yin; Haiyan Zhu
Journal:  Front Genet       Date:  2021-12-01       Impact factor: 4.599

Review 9.  Cervical Cancer, Papillomavirus, and miRNA Dysfunction.

Authors:  Evelyn Gabriela Bañuelos-Villegas; María Fernanda Pérez-yPérez; Luis Marat Alvarez-Salas
Journal:  Front Mol Biosci       Date:  2021-12-10

10.  Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway.

Authors:  Xiaoxia Zheng; Yanan Zhu; Xiaoping Wang; Yanmei Hou; Yingji Fang
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.